SDC1 and Kawasaki disease: Previous studies showed that circulating endothelial glycocalyx components including syndecan-1 and HA were significantly elevated at the acute phase of Kawasaki disease and serum levels of syndecan-1 and HA were often applied to evaluate the vascular endothelial damage and the coronary artery lesions [92,93].